EHJ Dialogue on SGLT2 in heart failure

EHJ Dialogue with Prof. Bertram Pitt on mineralocorticoid receptor antagonists in CVDПодробнее

EHJ Dialogues: Heart Failure: from pathophysiology to treatment and beyondПодробнее

EHJ Dialogue with Prof. Faiez ZannadПодробнее

EHJ Dialogue January 2023Подробнее

Conversations in Heart Failure: Contextualizing Advances in SGLT Inhibition for Acute DecompensationПодробнее

EHJ Dialogue with Prof. Milton Packer on heart FailureПодробнее

Therapy for Heart Failure w/ Reduced Ejection Fraction - When & How to Introduce SGLT2 InhibitorsПодробнее

ESC TV Conversations - SGLT2 inhibitors – wonder drugs in Heart Failure and beyond?Подробнее

SGLT2 Inhibitors and Heart FailureПодробнее

EHJ Dialogue with Prof. Marc Pfeffer on PARADISE-MIПодробнее

Empagliflozin in Heart Failure with a Preserved Ejection FractionПодробнее

EHJ Dialogue with Prof. Gregory Lip on ABC ApproachПодробнее

EHJ Dialogue with Prof. Karen Sliwa on cardiovascular diseases in africaПодробнее

EHJ Today - Telemonitoring in HFПодробнее

EHJ Dialogue on the year 2022 in cardiovascular medicineПодробнее

EHJ Today - Beyond ejection fractionПодробнее

EHJ Dialogue December 2022Подробнее

EHJ Dialogues: Prof. Christopher Cannon discussing the VERTIS trialПодробнее

EHJ Dialogues: 400th anniversary of cardiologyПодробнее

EHJ Today - Betablockers in HFПодробнее